{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:52:00Z","timestamp":1791395520596,"version":"4.3.3"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015640","name":"Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology","doi-asserted-by":"publisher","award":["2022ZHFY02"],"award-info":[{"award-number":["2022ZHFY02"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015640","name":"Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology","doi-asserted-by":"publisher","award":["24-2RSC09043-32"],"award-info":[{"award-number":["24-2RSC09043-32"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015640","name":"Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology","doi-asserted-by":"publisher","award":["2025B11"],"award-info":[{"award-number":["2025B11"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2022CFB477"],"award-info":[{"award-number":["2022CFB477"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2023BCB149"],"award-info":[{"award-number":["2023BCB149"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jconrel.2025.114514","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:24:34Z","timestamp":1765412674000},"page":"114514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Escherichia coli Nissle 1917 outer membrane vesicles encapsulating oncolytic virus remodel tumor-associated macrophages and kill prostate cancer cells"],"prefix":"10.1016","volume":"390","author":[{"given":"Jian-Xuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimaiti","family":"Abudureyimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Zhou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ci-Xiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Dong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.114514_bb0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","article-title":"Treatment of advanced prostate cancer","volume":"70","author":"Teo","year":"2019","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114514_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1874467208666150716120551","article-title":"A new era of immunotherapy in prostate cancer","volume":"9","author":"Pizzola","year":"2016","journal-title":"Curr. Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114514_bb0020","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1470-2045(14)70189-5","article-title":"Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial","volume":"15","author":"Kwon","year":"2014","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114514_bb0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ccell.2020.08.007","article-title":"Nivolumab plus ipilimumab for metastatic castration-resistant prostate cancer: preliminary analysis of patients in the CheckMate 650 trial","volume":"38","author":"Sharma","year":"2020","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114514_bb0030","first-page":"181","article-title":"Activation of toll-like receptors signaling in non-small cell lung cancer cell line induced by tumor-associated macrophages","volume":"27","author":"Ke","year":"2015","journal-title":"Chin. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114514_bb0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41391-024-00825-z","article-title":"Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer","volume":"28","author":"Fang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28208","article-title":"The association between human papillomavirus and bladder cancer: evidence from meta-analysis and two-sample mendelian randomization","volume":"95","author":"Sun","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jconrel.2025.114514_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1182322","article-title":"The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M","volume":"13","author":"Sun","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-024-05937-7","article-title":"Comprehensive analysis of the interaction microbiome and prostate cancer: an initial exploration from multi-cohort metagenome and GWAS studies","volume":"23","author":"Ye","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0055","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1038\/s41467-023-38679-z","article-title":"Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy","volume":"14","author":"Ban","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114514_bb0060","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","article-title":"Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization","volume":"188","author":"Chang","year":"2025","journal-title":"Cell"},{"issue":"8038","key":"10.1016\/j.jconrel.2025.114514_bb0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0070","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/s41467-020-16602-0","article-title":"Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity","volume":"11","author":"Leventhal","year":"2020","journal-title":"Nat. Commun."},{"issue":"Pt 2","key":"10.1016\/j.jconrel.2025.114514_bb0075","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.semcancer.2021.09.006","article-title":"Bacteria-based immune therapies for cancer treatment","volume":"86","author":"Howell","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114514_bb0080","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/thno.85917","article-title":"Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors","volume":"14","author":"Zheng","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0085","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2511355","article-title":"Translational horizons in bacterial membrane vesicles: hotspots and frontiers from basic medicine to clinical application by bibliometric analysis","volume":"21","author":"Sun","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114514_bb0090","article-title":"Immune responses elicited by outer membrane vesicles of gram-negative bacteria: important players in vaccine development","volume":"14","author":"Velimirov","year":"2024","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0095","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41467-017-00729-8","article-title":"Bacterial outer membrane vesicles suppress tumor by interferon-\u03b3-mediated antitumor response","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114514_bb0100","doi-asserted-by":"crossref","first-page":"16698","DOI":"10.1021\/acsnano.0c03776","article-title":"Bacterial outer membrane vesicles presenting programmed death 1 for improved cancer immunotherapy via immune activation and checkpoint inhibition","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"issue":"44","key":"10.1016\/j.jconrel.2025.114514_bb0105","doi-asserted-by":"crossref","first-page":"30332","DOI":"10.1021\/acsnano.4c07364","article-title":"Engineered outer membrane vesicles as nanosized immune cell engagers for enhanced solid tumor immunotherapy","volume":"18","author":"Sun","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114514_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216834","article-title":"OH2 oncolytic virus: a novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses","volume":"589","author":"Zheng","year":"2024","journal-title":"Cancer Lett."},{"issue":"22","key":"10.1016\/j.jconrel.2025.114514_bb0115","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1002\/cam4.4772","article-title":"A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer","volume":"11","author":"Dong","year":"2022","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114514_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002224","article-title":"Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I\/II clinical trial","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010543","article-title":"Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1\/2 trial","volume":"13","author":"Tan","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114514_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010662","article-title":"Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia\/Ib trial results and biomarker insights","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12964-025-02283-z","article-title":"Extracellular vesicles as missiles for enhanced anti-tumor efficacy of oncolytic viruses: from disseminating oncolysis and anti-tumor immunity to targeted delivery","volume":"23","author":"Safarzadeh","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jconrel.2025.114514_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217155","article-title":"Advances in and prospects of immunotherapy for prostate cancer","volume":"601","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114514_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.trecan.2020.01.003","article-title":"Immune checkpoint inhibition in prostate cancer","volume":"6","author":"Nicholson","year":"2020","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12916-025-04183-y","article-title":"Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors","volume":"23","author":"Lin","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.jconrel.2025.114514_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114085","article-title":"Bacteria and bacterial derivatives as delivery carriers for immunotherapy","volume":"181","author":"Kang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114514_bb0165","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1158\/1078-0432.CCR-07-4254","article-title":"Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging","volume":"14","author":"Brader","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"530","key":"10.1016\/j.jconrel.2025.114514_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"19","key":"10.1016\/j.jconrel.2025.114514_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417920","article-title":"TREM2 scFv-engineering Escherichia coli displaying modulation of macrophages to boost cancer radio-immunotherapy","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114514_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114321","article-title":"Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy","volume":"186","author":"Long","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114514_bb0240","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.vaccine.2005.09.043","article-title":"Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control","volume":"24","author":"Thornton","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114514_bb0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41565-024-01803-1","article-title":"Targeted intervention in nerve-cancer crosstalk enhances pancreatic cancer chemotherapy","volume":"20","author":"Qin","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"49","key":"10.1016\/j.jconrel.2025.114514_bb0190","doi-asserted-by":"crossref","first-page":"19585","DOI":"10.1021\/acs.analchem.4c04449","article-title":"Bioorthogonal engineering of bacterial outer membrane vesicles for NIR-II fluorescence imaging-guided synergistic enhanced immunotherapy","volume":"96","author":"Li","year":"2024","journal-title":"Anal. Chem."},{"issue":"13","key":"10.1016\/j.jconrel.2025.114514_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311222","article-title":"Bacterial outer membrane vesicles loaded with perhexiline suppress tumor development by regulating tumor-associated macrophages repolarization in a synergistic way","volume":"24","author":"Jiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114514_bb0245","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00640-25","article-title":"Efficacy of oncolytic virus in the treatment of intermediate-to-advanced solid tumors: a systematic review and meta-analysis","volume":"99","author":"Xu","year":"2025","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114514_bb0200","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mt.2010.297","article-title":"Oncolytic virus-initiated protective immunity against prostate cancer","volume":"19","author":"Gujar","year":"2011","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114514_bb0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrurol.2018.10","article-title":"Potentiating prostate cancer immunotherapy with oncolytic viruses","volume":"15","author":"Lee","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114514_bb0210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2025.114514_bb0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2018.05.015","article-title":"Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment","volume":"283","author":"Garofalo","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114514_bb0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2016.02.025","article-title":"Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy","volume":"89","author":"Ran","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0225","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1038\/s41467-024-48032-7","article-title":"Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114514_bb0250","article-title":"Sophora flavescens-derived extracellular vesicles loaded with oncolytic vaccinia virus\/IR1061 for NIR-II photoacoustic imaging guided multimodal treatment of diffuse large B-cell lymphoma","volume":"34","author":"Ji","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114514_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-023-35917-2","article-title":"Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114514_bb0235","article-title":"Dual-responsive epigenetic inhibitor nanoprodrug combined with oncolytic virus synergistically boost cancer immunotherapy by igniting Gasdermin E-mediated pyroptosis","author":"Wang","year":"2024","journal-title":"ACS Nano"}],"updated-by":[{"DOI":"10.1016\/j.jconrel.2026.114633","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000}}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:16:47Z","timestamp":1781702207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925011289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S0168365925011289"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114514","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Escherichia coli Nissle 1917 outer membrane vesicles encapsulating oncolytic virus remodel tumor-associated macrophages and kill prostate cancer cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114514"}}